A型肉毒杆菌毒素治疗眼睑痉挛的临床分析
Clinical Analysis of Botulinum Toxin Type A in the Treatment of Blepharospasm
DOI: 10.12677/hjo.2024.133010, PDF,   
作者: 张雅婷, 申 洁, 代应辉, 尹 群：蚌埠医学院第一附属医院眼科，安徽 蚌埠
关键词: A型肉毒杆菌毒素；特发性眼睑痉挛；Botulinum Toxin Type A； Blepharospasm
摘要: 目的：探讨眼睑局部注射A型肉毒杆菌对于眼睑痉挛的效果。方法：收集2022年7月~2024年2月被我院确诊为特发性眼睑痉挛的患者资料，筛选出其中符合条件者共78例作为研究对象。所有受试者均给予眼睑局部多点A型肉毒杆菌毒素治疗。本次研究中，选取的观察指标包括药疗效果、维持时间与不良反应。结果：A型肉毒杆菌毒素眼睑局部注射后，观察到痉挛症状大多1~7天完全缓解，有效治疗率约为98.7%。药物疗效大多可以维持3~6个月左右，并且并发症少。结论：A型肉毒杆菌毒素对于特发性眼睑痉挛患者进行眼睑局部注射治疗效果显著而且副作用少见，值得在临床上推广使用。
Abstract: Objective: To investigate the effect of local injection of Botulinum Toxin Type A into eyelid for blepharospasm. Methods: Data of patients diagnosed with idiopathic blepharospasm in our hospital from July 2022 to February 2024 were collected, and a total of 78 eligible patients were selected as research objects. All subjects were treated with local eyelid multipoint Botulinum Toxin Type A. In this study, the observational indicators included therapeutic effect, maintenance time and adverse reactions. Results: The symptoms of spasmodic were completely relieved in 1~7 days with an effective rate of 98.7%. The effect usually lasts for 3~6 mouths with few complications. Conclusion: Botulinum Toxin Type A given by local injection on multiple sites is more effective than acupuncture and moxibustion in the treatment of idiopathic ocular and facial spasmodic.
文章引用：张雅婷, 申洁, 代应辉, 尹群. A型肉毒杆菌毒素治疗眼睑痉挛的临床分析[J]. 眼科学, 2024, 13(3): 70-74. https://doi.org/10.12677/hjo.2024.133010

参考文献

[1] Titi-Lartey, O.A. and Patel, B.C. (2023) Benign Essential Blepharospasm. StatPearls Publishing, Treasure Island.
[2] 张伟, 朱晓冬. 单纯型肌张力障碍的神经影像学研究进展[J]. 国际神经病学神经外科学杂志, 2022, 49(5): 55-59.
[3] 武佳玮, 靳韬. 眼睑痉挛型Meige综合征的治疗进展[J]. 国际眼科杂志, 2023, 23(3): 421-424.
[4] 张鹏, 钟裕. 眼睑痉挛A型肉毒杆菌毒素注射不同点位的效果研究[J]. 基层医学论坛, 2023, 27(22): 8-11.
[5] Pandey, S. and Sharma, S. (2017) Meige’s Syndrome: History, Epidemiology, Clinical Features, Pathogenesis and Treatment. Journal of the Neurological Sciences, 372, 162-170. [Google Scholar] [CrossRef] [PubMed]
[6] Kent, T.L., Petris, C.K. and Holds, J.B. (2015) Effect of Upper Eyelid Myectomy on Subsequent Chemodenervation in the Management of Benign Essential Blepharospasm. Ophthalmic Plastic & Reconstructive Surgery, 31, 222-226. [Google Scholar] [CrossRef] [PubMed]
[7] 徐晓红, 徐凯, 彭琦, 等. A型肉毒素注射与眶周全肌切除术治疗特发性眼睑痉挛的比较[J]. 国际眼科杂志, 2016, 16(10): 1962-1964.
[8] 杨安, 胡怀彬, 张志芳, 等. 针刺联合A型肉毒素治疗特发性眼睑痉挛的临床观察[J]. 中国中医眼科杂志, 2023, 33(12): 1129-1133+1154.
[9] 赵晶晶. 良性特发性眼睑痉挛的研究与治疗新进展[J]. 中国疗养医学, 2019, 28(11): 1147-1150.
[10] Kim, J.E. and Jung, J.W. (2020) Refractory Dry Eye Disease Associated with Meige’s Syndrome Induced by Long-Term Use of an Atypical Antipsychotic. BMC Ophthalmology, 20, Article No. 474. [Google Scholar] [CrossRef] [PubMed]
[11] Peciña, M., Sikora, M., Avery, E.T., Heffernan, J., Peciña, S., Mickey, B.J., et al. (2017) Striatal Dopamine D2/3 Receptor-Mediated Neurotransmission in Major Depression: Implications for Anhedonia, Anxiety and Treatment Response. European Neuropsychopharmacology, 27, 977-986. [Google Scholar] [CrossRef] [PubMed]
[12] 徐国芬, 鲍晖, 王雪林, 等. A型肉毒素治疗面肌和眼睑痉挛的临床研究[J]. 中国现代医生, 2008, 46(36): 174+176.
[13] Wang, X., Mao, Z., Cui, Z., Xu, X., Pan, L., Liang, S., et al. (2020) Predictive Factors for Long-Term Clinical Outcomes of Deep Brain Stimulation in the Treatment of Primary Meige Syndrome. Journal of Neurosurgery, 132, 1367-1375. [Google Scholar] [CrossRef] [PubMed]
[14] 尹豆, 王含, 张玉虎, 等. 功能性运动障碍的诊断与治疗中国专家共识[J]. 重庆医科大学学报, 2021, 46(7): 732-736.
[15] 赵敏, 孙重. 两种不同浓度的A型肉毒素注射治疗眼睑痉挛的观察对比[J]. 国际眼科杂志, 2016, 16(8): 1587-1589.
[16] 田林, 杨全兴, 熊伟. A型肉毒素治疗眼睑、面肌痉挛的临床观察[J]. 中国现代医药杂志, 2013, 15(1): 74-75.
[17] 蒋真真, 汪美霞, 陶庄, 等. 汪美霞选用补中益气汤辨治Meige综合征临床经验[J]. 中医药临床杂志, 2024, 36(4): 653-656.
[18] 莫晔, 刘运宝. Meige综合征的临床诊治[J]. 中国冶金工业医学杂志, 2015, 32(1): 72-73.
[19] 刘伟. 眼周局部注射A型肉毒杆菌毒素联合干眼SPA治疗特发性眼睑痉挛的效果[J]. 中国当代医药, 2023, 30(5): 130-133.

为你推荐